WallStreetZenWallStreetZen

NASDAQ: PXMD
Paxmedica Inc Stock Forecast, Predictions & Price Target

Analyst price target for PXMD

Based on 1 analyst offering 12 month price targets for Paxmedica Inc.
Min Forecast
$3.00+275%
Avg Forecast
$3.00+275%
Max Forecast
$3.00+275%

Should I buy or sell PXMD stock?

Based on 1 analyst offering ratings for Paxmedica Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their PXMD stock forecasts and price targets.

PXMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-12-04

1 of 1

PXMD vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PXMD$0.80$3.00+275.00%Buy
XBIO$3.86N/AN/A
VCNX$4.84N/AN/A
ATXI$0.14$0.75+455.56%Strong Buy
FWBI$2.90$36.00+1,141.38%Strong Buy

Paxmedica Stock Forecast FAQ

Is Paxmedica Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: PXMD) stock is to Buy PXMD stock.

Out of 1 analyst, 0 (0%) are recommending PXMD as a Strong Buy, 1 (100%) are recommending PXMD as a Buy, 0 (0%) are recommending PXMD as a Hold, 0 (0%) are recommending PXMD as a Sell, and 0 (0%) are recommending PXMD as a Strong Sell.

If you're new to stock investing, here's how to buy Paxmedica stock.

What is PXMD's Price Target?

According to 1 Wall Street analyst that have issued a 1 year PXMD price target, the average PXMD price target is $3.00, with the highest PXMD stock price forecast at $3.00 and the lowest PXMD stock price forecast at $3.00.

The Wall Street analyst predicted that Paxmedica's share price could reach $3.00 by Dec 4, 2024. The average Paxmedica stock price prediction forecasts a potential upside of 275% from the current PXMD share price of $0.80.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.